Compare VYX & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VYX | BVS |
|---|---|---|
| Founded | 1881 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 994.1M | 910.2M |
| IPO Year | 1996 | 2016 |
| Metric | VYX | BVS |
|---|---|---|
| Price | $9.28 | $9.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $13.29 | ★ $16.60 |
| AVG Volume (30 Days) | ★ 2.8M | 625.9K |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | 0.09 | ★ 0.60 |
| Revenue | ★ $7,156,000,000.00 | $568,087,000.00 |
| Revenue This Year | N/A | $4.72 |
| Revenue Next Year | N/A | $6.41 |
| P/E Ratio | $105.33 | ★ $16.59 |
| Revenue Growth | ★ 15.29 | N/A |
| 52 Week Low | $6.02 | $7.02 |
| 52 Week High | $11.31 | $15.89 |
| Indicator | VYX | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 50.85 | 28.59 |
| Support Level | $6.46 | $9.82 |
| Resistance Level | $9.32 | $11.00 |
| Average True Range (ATR) | 0.63 | 0.61 |
| MACD | -0.09 | -0.13 |
| Stochastic Oscillator | 28.60 | 3.07 |
NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.